...
...
Next Story

Health Talk: What the US healthcare revamp plan means for the world

The USFDA is expected to be the hardest hit with 3,500 job cuts, US CDC will lose around 2,400 people, and the NIH will be down by 1,200 employees.

Updated on: Mar 30, 2025, 11:35:19 IST
Advertisement

It all started with the US announcing to pull out as a member of the United Nations health body — the World Health Organisation — almost immediately after President Donald Trump took over for a second term in January this year.

PREMIUMPeople protest as the USAID building sits closed to employees in Washington, DC, on February 3. (Reuters)
People protest as the USAID building sits closed to employees in Washington, DC, on February 3. (Reuters)

One move after the other led to his administration practically dismantling USAID by sending its workers on paid leave in February, and US health secretary Robert F Kennedy Jr on Thursday announcing plans to cut a quarter of his

It all started with the US announcing to pull out as a member of the United Nations health body — the World Health Organisation — almost immediately after President Donald Trump took over for a second term in January this year.

PREMIUMPeople protest as the USAID building sits closed to employees in Washington, DC, on February 3. (Reuters)
People protest as the USAID building sits closed to employees in Washington, DC, on February 3. (Reuters)

One move after the other led to his administration practically dismantling USAID by sending its workers on paid leave in February, and US health secretary Robert F Kennedy Jr on Thursday announcing plans to cut a quarter of his department’s workforce as part of a massive overhaul.

Under the announced plan, Kennedy Jr is looking at eliminating 10,000 positions, which is likely to reduce his department’s strength from 82,000 to 62,000 workers. The announcement will have a wider adverse impact as the number of workers of key US government health agencies such as US Food and Drug Administration (FDA), US Centre for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) will also come down.

As per reports, the USFDA is expected to be the hardest hit with 3,500 job cuts, US CDC will lose around 2,400 people, and the NIH will be down by 1,200 employees.

Not just for domestic healthcare space, these announcements are bad news for the world. India, for example, is a big market for US pharmaceutical companies and our regulators closely follow drug approvals issued by USFDA. Also, the alerts issued by US CDC work as reference point for many diseases. And key health programmes run by UN health agencies globally not getting adequate funds — there are also murmurs that the US may stop funding Gavi, the vaccine alliance — would mean bad news for low- and middle-income countries that are dependent on drugs and vaccines under these programmes.

In one of its recent reports — even though one cannot ignore their timing as they were released within weeks of US making these crucial announcements — the Lancet Global Health highlighted the impact of aid sanctions that they found led to increase in infant and maternal deaths.

Imposing aid sanctions is associated with a significant annual increase in death rates for infants (3.1%), children under 5 (3.6%), and mothers (6.4%) in sanctioned countries, said the paper. The study found that over a five-year period, aid sanctions effectively negated nearly 30% of the progress made in reducing infant and under-five deaths and reversed 60% of the improvements in maternal deaths achieved in low- and middle-income countries during the same timeframe.

Though the announcements the US currently made don’t really fall into the category of aid sanctions, the message of restricting funds by able members can still adversely impact progresses made in the health sector by weaker nations, and that message is loud and clear.

All Access.
One Subscription.

Get 360° coverage—from daily headlines
to 100 year archives.

E-Paper
Full
Archives
Full Access to
HT App & Website
Games
 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Are you a cricket buff? Participate in the HT Cricket Quiz daily and stand a chance to win an iPhone 15 & Boat Smartwatch. Click here to participate now.

Catch your daily dose of Fashion, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Are you a cricket buff? Participate in the HT Cricket Quiz daily and stand a chance to win an iPhone 15 & Boat Smartwatch. Click here to participate now.

Catch your daily dose of Fashion, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe